<DOC>
	<DOCNO>NCT02278913</DOCNO>
	<brief_summary>Few randomized study focus optimal management non-ICU patient type 2 diabetes Latin America . Objective : Compare safety efficacy basal bolus regimen analog human insulins general medicine patient admit University Hospital Asuncion , Paraguay .</brief_summary>
	<brief_title>Basal Bolus Versus Human Insulin Hospitalized Patients With Diabetes Paraguay</brief_title>
	<detailed_description>Few randomize intervention inpatient trial conduct Latin America determine optimal treatment regimens patient type 2 diabetes . In absence regional guideline , international society Latin America recommend follow international guideline management hospitalized patient diabetes . However , hospital resource , admission cause inpatient glycemic control differ among country . In US , lead cause admission hospital patient diabetes cardiovascular disease , whereas infection acute complication diabetes common cardiovascular disease country . The safety efficacy insulin regimens non-ICU set Latin country determine . Objective : compare efficacy safety basal-bolus regimen use insulin analog glargine daily plus glulisine meal human insulin NPH twice daily regular insulin meal medicine patient type 2 diabetes Outcome measure . To determine difference glycemic control group measure mean daily BG concentration hospital stay . Secondary outcome include difference treatment group follow measure : number hypoglycemic event ( BG &lt; 70 mg/dL &lt; 40 mg/dL ) , total daily dose insulin , length hospital stay , hospital complication mortality .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Age &gt; 18 year History type 2 diabetes &gt; 1 month Treatment diet alone , combination oral antidiabetic agent , and/or insulin prior admission Absence diabetic ketoacidosis No history diabetes Subjects expect undergo surgery hospitalization course Clinically relevant hepatic disease Impaired renal function ( serum creatinine â‰¥ 3.0 mg/dL ) Pregnancy Any mental condition render subject unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>inpatient</keyword>
	<keyword>hospital</keyword>
	<keyword>randomize trial</keyword>
	<keyword>diabetes</keyword>
	<keyword>analog</keyword>
	<keyword>human insulin</keyword>
</DOC>